tapebrief
WTW · Q3 2025
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

WTW · Q4 2025 Earnings

Willis Towers Watson

Reported February 3, 2026

30-second summary

Q4 revenue of $2.94B was down 3% reported but organic growth came in at 6.0% (R&B +7% organic / +10% reported on $1.25B revenue; HWC +6% organic), with adjusted operating margin expanding to 36.9% and adjusted EPS at $8.12 (+2% YoY, or +13% ex-TRANZACT). Management closed FY2025 with 5% organic growth, $1.55B FCF (15.9% margin), and $1.65B of buybacks — clearing the ~$1.5B guide. The FY2026 setup is dense: mid-to-high single-digit R&B growth, ~100bps R&B margin expansion (2-yr average), Newfront contributing ~$250M revenue at ~26% EBITDA margin but $0.10 dilutive, a Willis Re JV $0.30 EPS headwind, and a $0.30 FX tailwind (primarily Q1) that approximately offsets the JV drag.

Headline numbers

EPS

Q4 FY2025

$8.12

Revenue

Q4 FY2025

$2.94B

-3.0% YoY

Operating margin

Q4 FY2025

34.6%

Key financials

Q4 FY2025
MetricQ4 FY2025YoYQ3 FY2025QoQ
Revenue$2.94B-3.0%$2.29B+28.3%
EPS$8.12—$3.07+164.5%
Operating margin34.6%—18.3%+1630bps

Guidance

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

MetricPeriodGuideYoY
Health Organic GrowthFY 2026High single-digit growth—
Wealth GrowthFY 2026High end of the low single-digit range—
Career GrowthFY 2026Mid-single-digit growth—
BDNO GrowthFY 2026Low single-digit growth—
CRB GrowthFY 2026Mid to high single digit growth—
ICT GrowthFY 2026Low to mid single digit growth—
R&B Overall GrowthFY 2026Mid to high single-digit growth—
R&B Margin ExpansionFY 2026~100 basis points of average annual margin expansion over the next 2 years—
HWC Margin ExpansionFY 2026Continued margin expansion expected—
Willis Re JV EPS ImpactFY 2026~$0.30 headwind—
Newfront Acquisition EPS ImpactFY 2026~$0.10 dilutive—
Newfront Expected RevenueFY 2026~$250M—
Newfront Adjusted EBITDA MarginFY 2026~26%—
Foreign Exchange EPS TailwindFY 2026~$0.30 tailwind at current spot rates, primarily in Q1—

Segment performance

Q4 FY2025
SegmentQ4 FY2025YoY
Health, Wealth & Career$1.648B-11.0%
Risk & Broking$1.253B+10.0%

Capital & returns

Q4 FY2025
SegmentQ4 FY2025
Share Repurchases (Full Year)$1.65B

Other KPIs

Q4 FY2025
SegmentQ4 FY2025
Organic Revenue Growth (Q4)6.0%
Adjusted Operating Margin (Q4)36.9%
Adjusted EBITDA (Q4)$1.121B
Adjusted EBITDA Margin (Q4)38.2%
HWC Operating Margin44.3%
Risk & Broking Operating Margin34.7%
Organic Revenue Growth (Full Year)5.0%

Management tone

Customer optimization hangover (Q2) → Specialty growth proof points (Q3) → Strategic portfolio offense (Q4)

Pricing pressure narrative inverted. In Q2 management warned that a softer pricing environment could make high-single-digit growth harder; by Q4 the same risk is framed as a manageable headwind that specialty wins are out-running. In the Q&A, Lucy Clark (President of R&B) told Elise Greenspan that "our growth is driven by high retention rates, new business…and the success of the specialty strategy" — with digital infrastructure and electrification cited as specific offsets. The shift signals management has visibility into a deeper book of specialty business and no longer treats broking pricing as the binding constraint on R&B growth.

Portfolio activity reframed from defense to offense. Two quarters ago, divestitures (TRANZACT) were the dominant portfolio story and the optics were defensive. This quarter the company simultaneously announced Newfront, Cushion, and Flowstone, with Carl framing them as "a disciplined and deliberate approach to portfolio optimization aligned with the strategic priorities and financial framework we laid out at our 2024 Investor Day." The buyback guide stepping down from $1.5B to ≥$1.0B is the financial fingerprint of this shift — capital is flexing toward M&A integration, not away from shareholders.

WeDo / AI moved from pilot to operating model. Earlier in 2025 AI and automation were positioned as efficiency experiments with unclear ROI timing. In Q4, management framed WeDo as a critical driver of operating margin expansion in 2025 and expects continued benefits as WTW scales automation, expands delivery centers, and further embeds these capabilities across the firm. The 36.9% Q4 adjusted operating margin print gives the claim quantitative support, and it reframes the FY2026 margin expansion guide as structural rather than cyclical.

Digital infrastructure went from theme to franchise. Carl flagged "five of the 10 largest data center developers globally" as clients, with one recently won in a competitive RFP. A year ago this category was an emerging-opportunity bullet; in Q4 it sits alongside electrification as a named driver of R&B's growth.

Recurring themes management leaned on this quarter:

Specialization strategy driving sustainable organic growth across all regions and linesAI and automation delivering quantified margin expansion and operational leveragePortfolio optimization through disciplined M&A aligned with growth strategyTalent investments yielding above-expectation returns and embedded value creationDigital infrastructure and electrification as high-growth, high-margin opportunitiesConsistent margin expansion across segments despite macroeconomic uncertainty

Risks management surfaced:

Persistent challenging pricing environment in broking lines could limit upside to growth guidanceMedicare market changes creating modest near-term headwind to BDNO growth in 2026Consulting environment remains weak with clients cautious on multi-year technology implementation decisionsIntegration risks from New Front, Cushion, and Flowstone acquisitions could impact synergy realizationMacroeconomic uncertainty and potential headwinds require close monitoring and appropriate response

Answers to last quarter's watch list

HWC organic growth holding mid-single digits in Q4 with sub-segment balance — HWC organic grew 6% in Q4 (reported -11% on the TRANZACT lap), and the FY2026 sub-segment guides (Health high single-digit, Wealth high end of low single-digit, Career mid single-digit, BDNO low single-digit) imply the composite mid-single-digit framework is intact, with BDNO stepping down from mid- to low-single-digit on Medicare market headwinds.
Resolved positively
Whether ICT revenue inflects from flat back to growth — Management guided ICT to low- to mid-single-digit growth for FY2026 and explicitly said they "do not expect to see a meaningful pickup in consulting activity in the short term." The cautious client spend persists.
Resolved negatively
Whether R&B organic holds at or above 6% in Q4 — R&B Q4 organic was 7%, above the 6% threshold (reported +10% with FX tailwind), and CRB guidance for FY2026 was reaffirmed at mid- to high-single-digit.
Resolved positively
Q4 buyback pace and whether FY total lands at, above, or below ~$1.5B — FY2025 buybacks totaled $1.65B, above the ~$1.5B guide.
Resolved positively
Q4 free cash flow trajectory building on 9M FCF of $838M — FY FCF came in at $1.546B (15.9% margin), implying Q4 FCF of ~$708M against 9M of $838M. The H2 ramp Krasner guided to in Q2 materialized.
Resolved positively
Adjusted operating margin in Q4 versus prior-year Q4 comparable — Q4 adjusted operating margin of 36.9% expanded 80bps from prior-year Q4 (the 25.2% FY adjusted operating margin came in +130bps YoY) and validates the FY expansion guide.
Resolved positively
Bain reinsurance JV update and whether the ~$0.10 net EPS headwind framework holds into FY2026 — The FY2026 framework now carries a ~$0.30 Willis Re JV EPS headwind, materially higher than the FY2025 net headwind framework, as the JV moves from startup to market entry. The increase is approximately offset by the new $0.30 FX tailwind.
Resolved negatively

What to watch into next quarter

Q1 FY2026 organic growth and whether the FX tailwind ($0.30, "primarily Q1") flatters reported EPS in line with management's framing — Q1 is the cleanest test of the FY EPS shape.

Newfront close timing and whether the ~$250M revenue / ~26% EBITDA margin / $0.10 dilution framework holds through integration disclosure in subsequent quarters.

Willis Re JV launch progress and whether the $0.30 FY2026 EPS headwind drifts as the JV moves toward market entry — any creep above $0.30 reopens the question of how much the FX tailwind is actually offsetting.

Whether R&B sustains organic growth in the mid-to-high single digits or whether the +7% Q4 organic print decelerates — the FY2026 guide implies management is not extrapolating Q4 reported growth (which included FX) forward.

ICT trajectory in H1 FY2026 — low- to mid-single-digit FY guide reaffirmed; any deterioration would put pressure on the R&B composite.

Buyback cadence in Q1/Q2 — the ≥$1.0B FY2026 floor implies a step-down from the $1.65B FY2025 actual, and the pace will reveal how much capital is being held for M&A.

Q1 HWC organic growth as the TRANZACT lap finally completes — the first quarter where reported and organic should converge for HWC.

Sources

  1. WTW Q4 FY2025 press release (Exhibit 99.1), SEC EDGAR filing dated 2026-02-03: https://www.sec.gov/Archives/edgar/data/1140536/000117184326000577/exh_991.htm
  2. WTW Q4 FY2025 earnings call prepared remarks and Q&A, 2026-02-03 (Lucy Clark / Elise Greenspan exchange referenced in tone section)
  3. WTW Q3 FY2025 Tapebrief (internal, for prior-quarter framework and watch-list resolution)
  4. WTW Q2 FY2025 Tapebrief (internal, for multi-quarter tone arc)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.